| Typicality: | 0.314 |
| Saliency: | 0.150 |
| against the cancer cells | 3 | transitive-object |
| into a response | 3 | other |
| vaccine → be engineered to trigger → an immune system response | 3 |
| vaccine → be designed to activate → immune system | 3 |
| vaccine → be designed to agitate → immune system | 3 |
| negative | neutral | positive |
| 0.233 | 0.675 | 0.092 |
| Raw frequency | 9 |
| Normalized frequency | 0.150 |
| Modifier score | 0.500 |
| Perplexity | 27.282 |